Clinical Trial Search

Primary: Proportion of Patients Achieving Total Posterior Vitreous Detachment (PVD) Without Creation of an Anatomical Defect — 13.8; 18.2; 31.3; 10 percentage of participants…

Primary: Subjective, Objective, Management, and Analytic (SOMA) Score — 1.59; 1.0 units on a scale

Primary: Number of Patients With an Overall Response of Complete Response (CR) or Partial Response (PR) — 0 participants

Primary: Geometric Mean Titers (GMT) After 1 Dose of Cell-culture-derived Vaccine (cTIV) or Egg-derived Vaccine (eTIV_f), Using the ANOVA Method. — 259; 306; 181; 320 Titer

Primary: Change in Craving for Cigarettes After Smoking Cues Versus Neutral Cues Using a Repeated Measure Design. — -.18; .12; 1.29 units on a scale — p=0.014

Primary: Percentage of Participants Achieving American College of Rheumatology 20% (ACR20) Response at Week 12 — 64.3; 77.8; 96.3; 80.8 Percentage of Participants

Primary: Pathological Complete Response After Preoperative Therapy With Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in Patients With HER-2 Positive Early Breast…

Primary: Tumor Response Type: CR, PR, SD or PD — 1; 4; 9; 6 Participants

Primary: Number of Hepatitis B (HB)-Specific Cluster of Differentiation 4 (CD4+) T Cells . — 1345; 1257; 647; 391 HB-CD4+ T cells (per million cells)

Primary: Retention in Treatment — 7; 5; 6 participants — p=0.32

Primary: Hallucination Change Score - Right (HCS-right) — 7.78; 9.30 units on a scale

Primary: Immune Response — 7 Particpants

Primary: Overall Response — 1 participants

Primary: Overall Response Rate (ORR), the Percentage of Patients Who Experience an Objective Benefit From Treatment — 57 percentage of participants

Primary: Measurement of Serum Ketones Before and After Administration of Intravenous Fluids for Acute Gastroenteritis — 1.10; 2.39 mmol/L — p=0.0003